Cargando…
Behavioral Intervention versus Pharmacotherapy or Their Combinations in the Management of Overactive Bladder Dysfunction
Overactive bladder syndrome (OAB) refers to individuals with the following symptoms: urinary urgency, increased urinary frequency, and urge incontinence. These symptoms are not life threatening but can cause embarrassment and significantly impact quality of life. There are numerous treatment options...
Autores principales: | Tran, Khanh, Levin, Robert M., Mousa, Shaker A. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2796220/ https://www.ncbi.nlm.nih.gov/pubmed/20029638 http://dx.doi.org/10.1155/2009/345324 |
Ejemplares similares
-
Current pharmacotherapy of overactive bladder
por: Kreydin, Evgenyi I., et al.
Publicado: (2021) -
Overactive bladder syndrome pharmacotherapy: future treatment options
por: Wróbel, Andrzej
Publicado: (2015) -
NMDAR in bladder smooth muscle is not a pharmacotherapy target for overactive bladder in mice
por: Xie, Xiang, et al.
Publicado: (2021) -
Pharmacotherapy of overactive bladder in adults: a review of efficacy, tolerability, and quality of life
por: Jayarajan, Jyotsna, et al.
Publicado: (2013) -
Pharmacologic management of overactive bladder
por: Lam, Sum, et al.
Publicado: (2007)